Get the Stockscreener App
3.45
0.29%
0.01
After Hours:
3.79
0.34
+9.86%
Cumberland Pharmaceuticals Inc stock is traded at $3.45, with a volume of 32,453.
It is up +0.29% in the last 24 hours and up +2.99% over the past month.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
See More
Previous Close:
$3.44
Open:
$3.43
24h Volume:
32,453
Relative Volume:
0.48
Market Cap:
$51.62M
Revenue:
$37.79M
Net Income/Loss:
$-10.38M
P/E Ratio:
-4.726
EPS:
-0.73
Net Cash Flow:
$-1.00M
1W Performance:
+2.68%
1M Performance:
+2.99%
6M Performance:
+52.65%
1Y Performance:
+141.26%
1-Day Range:
$3.33
$3.5767
1-Week Range:
$3.25
$3.65
52-Week Range:
$1.04
$7.25
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Name
Cumberland Pharmaceuticals Inc
Sector
Phone
615-255-0068
Address
2525 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
3.45 | 51.47M | 37.79M | -10.38M | -1.00M | -0.73 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-12-12 | Reiterated | UBS | Neutral |
| Feb-01-11 | Reiterated | UBS | Neutral |
| Dec-16-10 | Downgrade | UBS | Buy → Neutral |
| Aug-17-10 | Downgrade | Jefferies | Buy → Hold |
| Aug-17-10 | Reiterated | Morgan Joseph | Buy |
| Aug-17-10 | Reiterated | UBS | Buy |
| May-14-10 | Reiterated | Morgan Joseph | Buy |
View All
Cumberland Pharmaceuticals Inc Stock (CPIX) Latest News
How Efficient Is Cumberland Pharmaceuticals Inc. at Controlling Operating CostsReal Time Alert System for Market Moves - Newser
Why Cumberland Pharmaceuticals Inc. stock attracts strong analyst attentionQuick Profit Setup with Signal Forecast - Newser
What are the technical indicators suggesting about Cumberland Pharmaceuticals Inc.Real Time Guidance For 2025 - jammulinksnews.com
Real time breakdown of Cumberland Pharmaceuticals Inc. stock performanceFree Risk Managed Intraday Trade Alerts - Newser
Understanding Cumberland Pharmaceuticals Inc.’s price movementTrading Opportunities Forecast by AI Insight - Newser
What data driven models say about Cumberland Pharmaceuticals Inc.’s futureEntry Zone Watchlist With Momentum Focus - Newser
Cumberland Pharmaceuticals Inc. Stock Performance After Earnings: Historical InsightsDaily Trade Setup Forecast with Confidence - Newser
Key External Factors That Drive Cumberland Pharmaceuticals Inc. Stock Price MovementsRisk Controlled Short Term Trade Plans Published - metal.it
How Cumberland Pharmaceuticals Inc. stock performs during market volatilityFree Low Capital High Return Stock Plans - Newser
Cumberland Pharmaceuticals Inc. Company Revenue and Profit Trends: A Deep DiveHigh Win Rate Trading Opportunities Detected - metal.it
Using portfolio simulators with Cumberland Pharmaceuticals Inc. includedLong-Term Signal Tracking and Profit Summary - Newser
Cumberland Pharmaceuticals Inc. recovery potential after sell off3-Year Equity Summary With Setup Insights - Newser
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q2 2025 FINANCIAL RESULTS & COMPANY UPDATE - 富途牛牛
MACD Cross Could Confirm Trend in Cumberland Pharmaceuticals Inc.Stock Portfolio Allocation Guidance for Volatile Markets - metal.it
How to recover losses in Cumberland Pharmaceuticals Inc. stockBuy Point Strategy with Profit Protection - Newser
Fibonacci Retracement Aligns with Support in Cumberland Pharmaceuticals Inc.Strong Buy With Technical Confidence Supported - beatles.ru
Traders Watching For Reversal Pattern in Cumberland Pharmaceuticals Inc.Weekly Stock Watch With Growth Focus Expanded - metal.it
Why is Cumberland Pharmaceuticals Inc. stock attracting strong analyst attentionStock Strategy Data Feed With High Returns - jammulinksnews.com
Duchenne Muscular Dystrophy Market to Witness Significant Expansion During the Forecast Period (2025–2034) Amidst Advances in Gene Therapy and Novel Drug Approvals | DelveInsight - GlobeNewswire Inc.
How does Cumberland Pharmaceuticals Inc. generate profit in a changing economyExplosive earnings growth - jammulinksnews.com
Using portfolio simulators with Cumberland Pharmaceuticals Inc. included Predictive System for Long-Term Stock Forecast - Newser
Top chart patterns to watch in Cumberland Pharmaceuticals Inc. Free Smart Allocation Stock Pick Insights - Newser
Should I hold or sell Cumberland Pharmaceuticals Inc. stock in 2025Massive stock growth - jammulinksnews.com
What catalysts could drive Cumberland Pharmaceuticals Inc. stock higher in 2025Get real-time updates on market trends - jammulinksnews.com
What are Cumberland Pharmaceuticals Inc. company’s key revenue driversPowerful market insights - jammulinksnews.com
Is Cumberland Pharmaceuticals Inc. stock overvalued or undervaluedDynamic profit expansion - jammulinksnews.com
Is Cumberland Pharmaceuticals Inc. a good long term investmentSuperior portfolio returns - PrintWeekIndia
What analysts say about Cumberland Pharmaceuticals Inc. stockFree Advanced Stock Screener Access - Autocar Professional
What drives Cumberland Pharmaceuticals Inc. stock priceAccelerated wealth building - Autocar Professional
In the last, let's say, three days this week, list out the companies that have the most insider buys - AInvest
Cumberland Pharmaceuticals Inc. Stock Analysis and ForecastTremendous portfolio expansion - jammulinksnews.com
Cumberland Pharmaceuticals Inc Stock (CPIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):